FDA Announces Emergency Authorization for Covid-19 Treatment

What Happened:

• The US Food and Drug Administration issued an emergency use authorization for the use of convalescent plasma to treat Covid-19 on Sunday, saying the "known and potential benefits of the product outweigh the known and potential risks of the product."

• Trump deemed the treatment a “major breakthrough."

• According to the FDA, more than 70,000 patients have been treated using convalescent plasma. Convalescent plasma is made using the blood of people who have recovered from coronavirus infections.

• Said Trump at a White House Press Briefing, "Today I am pleased to make a truly historic announcement in our battle against the China virus that will save countless lives...Today's action will dramatically increase access to this treatment."

Developing Story

Photo Credit: qimono